4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000168
Chairperson & CEO sold 9,500 shares at an average $553.87 ($5,261,741)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
18 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-20 | Sale : show line 2 in the form 10b5-1 | −117 | $546.84 | $63,981 | 333,826 | I |
| 2026-10-20 | Sale : show line 3 in the form 10b5-1 | −575 | $547.79 | $314,977 | 333,251 | I |
| 2026-10-20 | Sale : show line 4 in the form 10b5-1 | −948 | $548.95 | $520,400 | 332,303 | I |
| 2026-10-20 | Sale : show line 5 in the form 10b5-1 | −586 | $550.02 | $322,311 | 331,717 | I |
| 2026-10-20 | Sale : show line 6 in the form 10b5-1 | −1,134 | $551.03 | $624,870 | 330,583 | I |
| 2026-10-20 | Sale : show line 7 in the form 10b5-1 | −1,560 | $551.85 | $860,883 | 329,023 | I |
| 2026-10-20 | Sale : show line 8 in the form 10b5-1 | −240 | $553.14 | $132,754 | 328,783 | I |
| Open-market sales · 9,500 sh · avg $553.87 · $5,261,741 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-20 | Exercise or conversion : show line 19 in the form 10b5-1 Stock Option | −9,500 | 195,410 | I |
Loading xslF345X06/primarydocument.xml…